2024 Q2 Form 10-Q Financial Statement

#000141057824000999 Filed on June 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $2.969B $2.930B $5.435B
YoY Change -49.13% -15.47%
Cost Of Revenue $2.276B $2.220B $3.604B
YoY Change -41.36% -17.51%
Gross Profit $693.0M $710.0M $1.831B
YoY Change -64.57% -11.16%
Gross Profit Margin 23.34% 24.23% 33.69%
Selling, General & Admin $389.0M $380.0M $1.207B
YoY Change -66.95% -1.87%
% of Gross Profit 56.13% 53.52% 65.92%
Research & Development $10.81M
YoY Change 28.56%
% of Gross Profit 0.59%
Depreciation & Amortization $308.0M $327.0M
YoY Change 0.0% -48.1%
% of Gross Profit 44.44% 17.86%
Operating Expenses $389.0M $380.0M $1.207B
YoY Change -66.95% -1.87%
Operating Profit $304.0M $330.0M $624.0M
YoY Change -60.98% -24.91%
Interest Expense -$33.00M -$25.00M -$52.00M
YoY Change -57.69% -36.59%
% of Operating Profit -10.86% -7.58% -8.33%
Other Income/Expense, Net -$24.00M -$15.00M -$35.00M
YoY Change 200.0% -683.33%
Pretax Income -$12.30K $267.0M $396.0M
YoY Change -100.0% -24.43%
Income Tax $55.00M $76.00M $113.0M
% Of Pretax Income 28.46% 28.54%
Net Earnings -$12.30K $191.0M $282.0M
YoY Change -23.78%
Net Earnings / Revenue 0.0% 6.52% 5.19%
Basic Earnings Per Share -$2.56
Diluted Earnings Per Share -$2.56 $0.37 $1.08
COMMON SHARES
Basic Shares Outstanding 100.0
Diluted Shares Outstanding 4.803K

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.76K $110.00 $905.0M
YoY Change -100.0% 16.47%
Cash & Equivalents $26.76K $108.00 $111.00
Short-Term Investments
Other Short-Term Assets $30.00M
YoY Change -70.59%
Inventory $1.023B
Prepaid Expenses
Receivables $2.084B
Other Receivables $39.00M
Total Short-Term Assets $26.76K $110.00 $4.081B
YoY Change -100.0% -9.49%
LONG-TERM ASSETS
Property, Plant & Equipment $5.638B
YoY Change 11.07%
Goodwill $2.842B
YoY Change
Intangibles $218.0M
YoY Change
Long-Term Investments $29.00M
YoY Change 11.54%
Other Assets $159.0M
YoY Change -0.63%
Total Long-Term Assets $2.00 -$2.00 -$4.081B
YoY Change -100.0% -151.19%
TOTAL ASSETS
Total Short-Term Assets $26.76K $110.00 $4.081B
Total Long-Term Assets $2.00 -$2.00 -$4.081B
Total Assets $26.76K $108.00 $111.00
YoY Change -100.0% -100.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.30K $2.378B
YoY Change -100.0% -9.99%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $175.0M
YoY Change -2.78%
Total Short-Term Liabilities $12.30K $2.694B
YoY Change -100.0% -11.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $3.570B
YoY Change -100.0% -0.83%
Other Long-Term Liabilities $619.0M
YoY Change -1.28%
Total Long-Term Liabilities $0.00 $0.00 $4.189B
YoY Change -100.0% -0.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.30K $2.694B
Total Long-Term Liabilities $0.00 $0.00 $4.189B
Total Liabilities $12.30K $7.068B
YoY Change -100.0% -5.22%
SHAREHOLDERS EQUITY
Retained Earnings -$12.30K $3.521B
YoY Change
Common Stock $114.00 $114.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.46K $108.00 $111.00
YoY Change
Total Liabilities & Shareholders Equity $26.76K $110.00 $111.00
YoY Change -100.0% -100.0%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$12.30K $191.0M $282.0M
YoY Change -23.78%
Depreciation, Depletion And Amortization $308.0M $327.0M
YoY Change 0.0% -48.1%
Cash From Operating Activities $0.00 $0.00 $951.0M
YoY Change -100.0% -34.5%
INVESTING ACTIVITIES
Capital Expenditures $385.0M $434.0M
YoY Change -9.41% -51.24%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $17.00M
YoY Change -100.0% -122.08%
Cash From Investing Activities $0.00 $0.00 -$417.0M
YoY Change -100.0% -56.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 26.85K 0.000 -218.0M
YoY Change -100.01% -56.05%
NET CHANGE
Cash From Operating Activities 0.000 0.000 951.0M
Cash From Investing Activities 0.000 0.000 -417.0M
Cash From Financing Activities 26.85K 0.000 -218.0M
Net Change In Cash 26.85K 0.000 316.0M
YoY Change -100.01% -2972.73%
FREE CASH FLOW
Cash From Operating Activities $0.00 $0.00 $951.0M
Capital Expenditures $385.0M $434.0M
Free Cash Flow -$385.0M $517.0M
YoY Change -373.05% -8.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0002005951
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
SMURFIT WESTROCK LIMITED
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L2
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1776979
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
Beech Hill, Clonskeagh
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin 4
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
D04 N2R2
CY2024Q1 dei Entity Address Country
EntityAddressCountry
IE
CY2024Q1 dei City Area Code
CityAreaCode
+353
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
1 202 7000
CY2024Q1 dei Security12b Title
Security12bTitle
Ordinary shares of $0.001 each
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
true
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
100
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
111
CY2024Q1 us-gaap Assets
Assets
108
CY2023Q4 us-gaap Assets
Assets
111
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
114
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
114
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
108
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
111
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
107
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
109
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
111
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
108
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001410578-24-000999-index-headers.html Edgar Link pending
0001410578-24-000999-index.html Edgar Link pending
0001410578-24-000999.txt Edgar Link pending
0001410578-24-000999-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20240331.xsd Edgar Link pending
tmb-20240331x10q.htm Edgar Link pending
tmb-20240331xex31d1.htm Edgar Link pending
tmb-20240331xex31d2.htm Edgar Link pending
tmb-20240331xex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
tmb-20240331_cal.xml Edgar Link unprocessable
tmb-20240331_def.xml Edgar Link unprocessable
tmb-20240331_lab.xml Edgar Link unprocessable
tmb-20240331_pre.xml Edgar Link unprocessable
tmb-20240331x10q_htm.xml Edgar Link completed